1357247-47-2 Usage
General Description
"(trans)-ethyl-2-(6-bromopyridin-3-yl)cyclopropanecarboxylate" is a chemical compound with the molecular formula C12H13BrNO2. It is a cyclopropanecarboxylate derivative that contains a cyclopropane ring, an ethyl group, and a 6-bromopyridin-3-yl group. (trans)-ethyl-2-(6-bromopyridin-3-yl)cyclopropanecarboxylate is commonly used in organic synthesis and medicinal chemistry for the development of new pharmaceuticals and biologically active molecules. It may have potential applications in the treatment of various medical conditions, and its structural features make it a valuable building block for the synthesis of more complex organic compounds. Further research and testing may reveal additional uses and properties of this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 1357247-47-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,7,2,4 and 7 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1357247-47:
(9*1)+(8*3)+(7*5)+(6*7)+(5*2)+(4*4)+(3*7)+(2*4)+(1*7)=172
172 % 10 = 2
So 1357247-47-2 is a valid CAS Registry Number.
1357247-47-2Relevant articles and documents
CYCLOPROPYLAMINE INHIBITORS OF OXIDASES
-
Paragraph 0440-0441, (2013/11/06)
The invention relates to cyclopropylamine compounds, in particular the compounds of Formula (I) as described and defined herein, and their use in therapy, including, e.g., the treatment or prevention of cancer.
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
-
Page/Page column 135; 136, (2013/05/09)
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection.
CYCLOPROPYLAMINE INHIBITORS OF OXIDASES
-
Page/Page column 83, (2012/04/23)
The invention relates to cyclopropylamine compounds, in particular the compounds of Formula (I) as described and defined herein, and their use in therapy, including, e.g., the treatment or prevention of cancer.
